Related Experiment Video
Updated: Feb 13, 2026

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
Mechanism-guided design of specific-activated photosensitizers for precision photodynamic therapy
Kai Wang1, Xiaoying Mao1, Wuyan Xie1
1College of Biotechnology and Bioengineering, Zhejiang University of Technology Chaowang Road 18 Hangzhou 310014 China zhuq@zjut.edu.cn.
Abstract:
The clinical application of conventional photodynamic therapy (PDT) is often limited by the nonspecific phototoxicity of "always-on" photosensitizers. Activatable photosensitizers (aPSs) have emerged as a promising solution to this challenge. These smart agents are designed to remain inactive under normal physiological conditions and become activated only by disease-specific stimuli, thereby significantly improving treatment specificity and safety. This review summarizes the key design strategies for developing effective aPSs. We focus on the general principles of utilizing various quenching mechanisms, such as energy or electron transfer processes and aggregation behavior control, to suppress photosensitizer activity until a specific trigger is encountered. Representative examples are discussed to illustrate how these designs respond to biomarkers like enzymes, glutathione, or acidic pH to activate therapeutic functions. By minimizing off-target effects and enhancing spatial control, these mechanism-guided approaches pave the way for more precise and clinically viable PDT protocols, aligning with the core objectives of precision medicine.
Insights
Activatable photosensitizers (aPSs) offer a safer approach to photodynamic therapy (PDT) by remaining inactive until triggered by disease-specific signals. This enhances treatment precision and minimizes side effects for improved clinical outcomes.
Area of Science:
- Biomedical Engineering
- Photochemistry
- Oncology
Background:
- Conventional photodynamic therapy (PDT) faces limitations due to nonspecific phototoxicity from always-on photosensitizers.
- Activatable photosensitizers (aPSs) offer a promising strategy to enhance treatment specificity and safety.
Purpose of the Study:
- To review key design strategies for developing effective activatable photosensitizers (aPSs).
- To highlight how quenching mechanisms and aggregation control enable stimulus-responsive aPS activation.
Main Methods:
- Summarizing design principles for aPSs, focusing on energy/electron transfer and aggregation control.
- Discussing representative examples of aPSs activated by disease-specific biomarkers (enzymes, glutathione, pH).
Main Results:
- aPSs can be designed to remain inactive until encountering specific disease biomarkers.
- Mechanism-guided activation minimizes off-target effects and enhances spatial control in PDT.
Conclusions:
- Activatable photosensitizers represent a significant advancement for precision medicine in photodynamic therapy.
- These smart agents enable more precise and clinically viable PDT protocols by responding to disease-specific stimuli.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Group Design
Uncertainty in Measurement: Accuracy and Precision
Reaction Mechanisms
For instance, the decomposition of ozone appears to follow a mechanism with two steps:
Gene Therapy
Factorial Design

